{"pmid":32425633,"pmcid":"PMC7231484","title":"Tracking the origin of early COVID-19 cases in Canada.","text":["Tracking the origin of early COVID-19 cases in Canada.","The original coronavirus disease (COVID-19) outbreak in Wuhan, China has become a global pandemic. By tracking the earliest 118 COVID-19 cases in Canada, we produced a Voronoi treemap to show the travel origins of the country's earliest COVID-19 cases. By March 11, 2020, even though the majority (64.1%) of the world's COVID-19 confirmed cases still had their origin in China, only 7.6% of Canada's first 118 COVID-19 cases arose due in travelers to China. The most commonly reported travel history among the 118 cases originated from the Middle East, the United States, and Europe. Thus, in retrospect, broadening of early screening tools and travel restrictions to countries and regions outside China may help control global COVID-19 spread.","Int J Infect Dis","Zhao, Naizhuo","Liu, Ying","Smaragiassi, Audrey","Bernatsky, Sasha","32425633"],"abstract":["The original coronavirus disease (COVID-19) outbreak in Wuhan, China has become a global pandemic. By tracking the earliest 118 COVID-19 cases in Canada, we produced a Voronoi treemap to show the travel origins of the country's earliest COVID-19 cases. By March 11, 2020, even though the majority (64.1%) of the world's COVID-19 confirmed cases still had their origin in China, only 7.6% of Canada's first 118 COVID-19 cases arose due in travelers to China. The most commonly reported travel history among the 118 cases originated from the Middle East, the United States, and Europe. Thus, in retrospect, broadening of early screening tools and travel restrictions to countries and regions outside China may help control global COVID-19 spread."],"journal":"Int J Infect Dis","authors":["Zhao, Naizhuo","Liu, Ying","Smaragiassi, Audrey","Bernatsky, Sasha"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32425633","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.ijid.2020.05.046","keywords":["covid-19","canada","voronoi treemap","travel"],"locations":["Wuhan","China","Canada","Voronoi","China","Canada","China","United States","China","Canada"],"countries":["China","United States","Canada"],"countries_codes":["CHN|China","USA|United States","CAN|Canada"],"topics":["Prevention"],"weight":1,"_version_":1667352728798494721,"score":9.490897,"similar":[{"pmid":32202489,"pmcid":"PMC7113321","title":"Risk of COVID-19 importation to the Pacific islands through global air travel.","text":["Risk of COVID-19 importation to the Pacific islands through global air travel.","On 30 January 2020, WHO declared coronavirus (COVID-19) a global public health emergency. As of 12 March 2020, 125 048 confirmed COVID-19 cases in 118 countries had been reported. On 12 March 2020, the first case in the Pacific islands was reported in French Polynesia; no other Pacific island country or territory has reported cases. The purpose of our analysis is to show how travellers may introduce COVID-19 into the Pacific islands and discuss the role robust health systems play in protecting health and reducing transmission risk. We analyse travel and Global Health Security Index data using a scoring tool to produce quantitative estimates of COVID-19 importation risk, by departing and arriving country. Our analysis indicates that, as of 12 March 2020, the highest risk air routes by which COVID-19 may be imported into the Pacific islands are from east Asian countries (specifically, China, Korea and Japan) to north Pacific airports (likely Guam, Commonwealth of the Northern Mariana Islands or, to a less extent, Palau); or from China, Japan, Singapore, the United States of America or France to south Pacific ports (likely, Fiji, Papua New Guinea, French Polynesia or New Caledonia). Other importation routes include from other east Asian countries to Guam, and from Australia, New Zealand and other European countries to the south Pacific. The tool provides a useful method for assessing COVID-19 importation risk and may be useful in other settings.","Epidemiol Infect","Craig, A T","Heywood, A E","Hall, J","32202489"],"abstract":["On 30 January 2020, WHO declared coronavirus (COVID-19) a global public health emergency. As of 12 March 2020, 125 048 confirmed COVID-19 cases in 118 countries had been reported. On 12 March 2020, the first case in the Pacific islands was reported in French Polynesia; no other Pacific island country or territory has reported cases. The purpose of our analysis is to show how travellers may introduce COVID-19 into the Pacific islands and discuss the role robust health systems play in protecting health and reducing transmission risk. We analyse travel and Global Health Security Index data using a scoring tool to produce quantitative estimates of COVID-19 importation risk, by departing and arriving country. Our analysis indicates that, as of 12 March 2020, the highest risk air routes by which COVID-19 may be imported into the Pacific islands are from east Asian countries (specifically, China, Korea and Japan) to north Pacific airports (likely Guam, Commonwealth of the Northern Mariana Islands or, to a less extent, Palau); or from China, Japan, Singapore, the United States of America or France to south Pacific ports (likely, Fiji, Papua New Guinea, French Polynesia or New Caledonia). Other importation routes include from other east Asian countries to Guam, and from Australia, New Zealand and other European countries to the south Pacific. The tool provides a useful method for assessing COVID-19 importation risk and may be useful in other settings."],"journal":"Epidemiol Infect","authors":["Craig, A T","Heywood, A E","Hall, J"],"date":"2020-03-24T11:00:00Z","year":2020,"_id":"32202489","source":"PubMed","week":"202013|Mar 23 - Mar 29","doi":"10.1017/S0950268820000710","keywords":["covid-19","coronavirus","pacific islands","surveillance","travel"],"locations":["French","China","South Korea","Japan","Guam","Palau","China","Japan","Singapore","France","Fiji","Papua New Guinea","French","New Caledonia","Guam","Australia","New Zealand"],"countries":["Australia","Korea, Republic of","Palau","Singapore","Papua New Guinea","New Caledonia","China","Japan","New Zealand","Fiji","France","Guam"],"countries_codes":["AUS|Australia","KOR|Korea, Republic of","PLW|Palau","SGP|Singapore","PNG|Papua New Guinea","NCL|New Caledonia","CHN|China","JPN|Japan","NZL|New Zealand","FJI|Fiji","FRA|France","GUM|Guam"],"topics":["Transmission","Prevention"],"weight":1,"_version_":1666138492405547011,"score":275.4169},{"pmid":32321369,"title":"Impact of population movement on the spread of 2019-nCoV in China.","text":["Impact of population movement on the spread of 2019-nCoV in China.","Since Dec 2019, China have experienced an outbreak caused by a novel coronavirus, 2019-nCoV. A travel ban was implemented for Wuhan, Hubei on Jan 23 to slow down the outbreak. We found a significant positive correlation between population influx from Wuhan and confirmed cases in other cities across China (R(2)=0.85, P <0.001), especially cities in Hubei (R(2)=0.88, P <0.001). Removing the travel restriction would have increased 118% (91%-172%) of the overall cases for the coming week, and a travel ban taken three days or a week earlier would have reduced 47% (26%-58%) and 83% (78%-89%) of the early cases. We would expect a 61% (48%-92%) increase of overall cumulative cases without any restrictions on returning residents, and 11% (8%-16%) increase if the travel ban stays in place for Hubei. Cities from Yangtze River Delta, Pearl River Delta, and Capital Economic Circle regions are at higher risk.","Emerg Microbes Infect","Zhang, Chi","Chen, Cai","Shen, Wei","Tang, Feng","Lei, Hao","Xie, Yu","Cao, Zicheng","Tang, Kang","Bai, Junbo","Xiao, Lehan","Xu, Yutian","Song, Yanxin","Chen, Jiwei","Guo, Zhihui","Guo, Yichen","Wang, Xiao","Xu, Modi","Zou, Huachun","Shu, Yuelong","Du, Xiangjun","32321369"],"abstract":["Since Dec 2019, China have experienced an outbreak caused by a novel coronavirus, 2019-nCoV. A travel ban was implemented for Wuhan, Hubei on Jan 23 to slow down the outbreak. We found a significant positive correlation between population influx from Wuhan and confirmed cases in other cities across China (R(2)=0.85, P <0.001), especially cities in Hubei (R(2)=0.88, P <0.001). Removing the travel restriction would have increased 118% (91%-172%) of the overall cases for the coming week, and a travel ban taken three days or a week earlier would have reduced 47% (26%-58%) and 83% (78%-89%) of the early cases. We would expect a 61% (48%-92%) increase of overall cumulative cases without any restrictions on returning residents, and 11% (8%-16%) increase if the travel ban stays in place for Hubei. Cities from Yangtze River Delta, Pearl River Delta, and Capital Economic Circle regions are at higher risk."],"journal":"Emerg Microbes Infect","authors":["Zhang, Chi","Chen, Cai","Shen, Wei","Tang, Feng","Lei, Hao","Xie, Yu","Cao, Zicheng","Tang, Kang","Bai, Junbo","Xiao, Lehan","Xu, Yutian","Song, Yanxin","Chen, Jiwei","Guo, Zhihui","Guo, Yichen","Wang, Xiao","Xu, Modi","Zou, Huachun","Shu, Yuelong","Du, Xiangjun"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32321369","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1080/22221751.2020.1760143","keywords":["2019-ncov","population movement","risk","spread","travel ban"],"locations":["China","Wuhan","Hubei","Wuhan","China","Hubei","Hubei","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666138493809590275,"score":237.42445},{"pmid":32093043,"pmcid":"PMC7073711","title":"Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China.","text":["Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China.","We developed a computational tool to assess the risks of novel coronavirus outbreaks outside of China. We estimate the dependence of the risk of a major outbreak in a country from imported cases on key parameters such as: (i) the evolution of the cumulative number of cases in mainland China outside the closed areas; (ii) the connectivity of the destination country with China, including baseline travel frequencies, the effect of travel restrictions, and the efficacy of entry screening at destination; and (iii) the efficacy of control measures in the destination country (expressed by the local reproduction number R loc ). We found that in countries with low connectivity to China but with relatively high R loc , the most beneficial control measure to reduce the risk of outbreaks is a further reduction in their importation number either by entry screening or travel restrictions. Countries with high connectivity but low R loc benefit the most from policies that further reduce R loc . Countries in the middle should consider a combination of such policies. Risk assessments were illustrated for selected groups of countries from America, Asia, and Europe. We investigated how their risks depend on those parameters, and how the risk is increasing in time as the number of cases in China is growing.","J Clin Med","Boldog, Peter","Tekeli, Tamas","Vizi, Zsolt","Denes, Attila","Bartha, Ferenc A","Rost, Gergely","32093043"],"abstract":["We developed a computational tool to assess the risks of novel coronavirus outbreaks outside of China. We estimate the dependence of the risk of a major outbreak in a country from imported cases on key parameters such as: (i) the evolution of the cumulative number of cases in mainland China outside the closed areas; (ii) the connectivity of the destination country with China, including baseline travel frequencies, the effect of travel restrictions, and the efficacy of entry screening at destination; and (iii) the efficacy of control measures in the destination country (expressed by the local reproduction number R loc ). We found that in countries with low connectivity to China but with relatively high R loc , the most beneficial control measure to reduce the risk of outbreaks is a further reduction in their importation number either by entry screening or travel restrictions. Countries with high connectivity but low R loc benefit the most from policies that further reduce R loc . Countries in the middle should consider a combination of such policies. Risk assessments were illustrated for selected groups of countries from America, Asia, and Europe. We investigated how their risks depend on those parameters, and how the risk is increasing in time as the number of cases in China is growing."],"journal":"J Clin Med","authors":["Boldog, Peter","Tekeli, Tamas","Vizi, Zsolt","Denes, Attila","Bartha, Ferenc A","Rost, Gergely"],"date":"2020-02-26T11:00:00Z","year":2020,"_id":"32093043","source":"PubMed","week":"20209|Feb 24 - Mar 01","doi":"10.3390/jcm9020571","keywords":["covid-19","branching process","compartmental model","interventions","novel coronavirus","outbreak","risk assessment","transmission","travel"],"locations":["China","China","China","China","America","China","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention","Epidemic Forecasting"],"weight":1,"_version_":1666138492918300676,"score":236.84099},{"pmid":32341630,"pmcid":"PMC7179067","title":"Tackling Corona Virus Disease 2019 (COVID 19) in Workplaces.","text":["Tackling Corona Virus Disease 2019 (COVID 19) in Workplaces.","Coronaviruses are zoonotic viruses and six species of Coronaviruses are known to cause human disease such as cause common cold, severe acute respiratory syndrome and the Middle East Respiratory Syndrome. In January 2020, scientists in Wuhan, China isolated a novel coronavirus (SARS-CoV-2), responsible for an outbreak of unknown pneumonia that had not been previously reported among humans. This virus spreads from person to person, through respiratory droplets, close contact, and by touching surfaces or objects contaminated by the virus. The incubation period varies between 2 days and 14 days. Symptoms usually include fever, cough, difficulty in breathing, pneumonia, severe acute respiratory syndrome. Older age and co-morbid conditions increase the fatality. Any person with a history of travel to and from COVID-19 affected countries in the past 14 days or any person who has had close contact with a laboratory confirmed COVID-19 are suspect cases and needs evaluation. Currently no vaccine is available and treatment is mainly supportive. Measures at workplace should include- avoiding non-essential travel, identifying and isolating sick employees at the earliest, hand hygiene, respiratory hygiene, environmental hygiene and social distancing.","Indian J Occup Environ Med","Ramesh, Naveen","Siddaiah, Archana","Joseph, Bobby","32341630"],"abstract":["Coronaviruses are zoonotic viruses and six species of Coronaviruses are known to cause human disease such as cause common cold, severe acute respiratory syndrome and the Middle East Respiratory Syndrome. In January 2020, scientists in Wuhan, China isolated a novel coronavirus (SARS-CoV-2), responsible for an outbreak of unknown pneumonia that had not been previously reported among humans. This virus spreads from person to person, through respiratory droplets, close contact, and by touching surfaces or objects contaminated by the virus. The incubation period varies between 2 days and 14 days. Symptoms usually include fever, cough, difficulty in breathing, pneumonia, severe acute respiratory syndrome. Older age and co-morbid conditions increase the fatality. Any person with a history of travel to and from COVID-19 affected countries in the past 14 days or any person who has had close contact with a laboratory confirmed COVID-19 are suspect cases and needs evaluation. Currently no vaccine is available and treatment is mainly supportive. Measures at workplace should include- avoiding non-essential travel, identifying and isolating sick employees at the earliest, hand hygiene, respiratory hygiene, environmental hygiene and social distancing."],"journal":"Indian J Occup Environ Med","authors":["Ramesh, Naveen","Siddaiah, Archana","Joseph, Bobby"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32341630","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.4103/ijoem.IJOEM_49_20","keywords":["containment","sars-cov 2","prevention","travel","workplace"],"locations":["Coronaviruses","Wuhan","China","Workplaces"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Treatment","Prevention"],"weight":1,"_version_":1666138495808176128,"score":213.65416},{"pmid":32328533,"pmcid":"PMC7167363","title":"Canada's role in strengthening global health security during the COVID-19 pandemic.","text":["Canada's role in strengthening global health security during the COVID-19 pandemic.","The world is confronted by the current pandemic of Corona Virus Disease (COVID-19), which is a wake-up call for all nations irrespective of their development status or geographical location. Since the start of the century we have seen five big infectious outbreaks which proved that epidemics are no more regarded as historic and geographically confined threats. The Canadian government underlined that these infectious disease outbreaks are threats to global health security and disrupt societal wellbeing and development. In this context, the Public Health Agency of Canada is proactive and has shown its preparedness for outbreaks of emerging and epidemic-prone diseases, and in dealing with these pathogens. Even before the declaration of pandemic, Canada has proved its global health leadership by ensuring collective action and multisectoral coordination which still remains a serious challenge especially for low and middle- income countries with existing poor health systems. In this article we discuss how Canada is addressing the global challenges posed by the COVID-19 pandemic through its leadership and practice of global health diplomacy.","Glob Health Res Policy","Chattu, Vijay Kumar","Adisesh, Anil","Yaya, Sanni","32328533"],"abstract":["The world is confronted by the current pandemic of Corona Virus Disease (COVID-19), which is a wake-up call for all nations irrespective of their development status or geographical location. Since the start of the century we have seen five big infectious outbreaks which proved that epidemics are no more regarded as historic and geographically confined threats. The Canadian government underlined that these infectious disease outbreaks are threats to global health security and disrupt societal wellbeing and development. In this context, the Public Health Agency of Canada is proactive and has shown its preparedness for outbreaks of emerging and epidemic-prone diseases, and in dealing with these pathogens. Even before the declaration of pandemic, Canada has proved its global health leadership by ensuring collective action and multisectoral coordination which still remains a serious challenge especially for low and middle- income countries with existing poor health systems. In this article we discuss how Canada is addressing the global challenges posed by the COVID-19 pandemic through its leadership and practice of global health diplomacy."],"journal":"Glob Health Res Policy","authors":["Chattu, Vijay Kumar","Adisesh, Anil","Yaya, Sanni"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32328533","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1186/s41256-020-00146-3","keywords":["covid-19","canada","coronavirus outbreak","epidemic","epidemic curve","global health security","pandemic","public health","public health emergency of international concern"],"locations":["Canadian","Canada","Canada","Canada","Canada"],"countries":["Canada"],"countries_codes":["CAN|Canada"],"topics":["Prevention"],"weight":1,"_version_":1666138494689345536,"score":190.99553}]}